The HCPLive spondyloarthritis page is a resource for medical news and expert insights on spondylitis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for autoimmune disease, and more.
May 6th 2024
Both overall TEAEs and serious TEAEs were numerically higher in those receiving upadacitinib compared with adalimumab.
American Medical Association Wins Concessions on ICD-10 Switch
Coming next from Medicare: the ICD-10 Obmudsman. Billing under the dreaded new International Classification of Diseases-10 (ICD-10) coding system will get a bit less onerous under a deal brokered between Medicare and the American Medical Association.
Big Gains at 2 Years of Ustekinumab in PsA
June 25th 2015Patients with psoriatic arthritis achieve significant improvements in signs and symptoms with the interleukin-12/23 inhibitor ustekinumab (Stelara), and they maintain those gains for 2 years, according to final results from 3 major clinical trials.
Biologics Help Inflammatory Arthritis Patients Get Back to Work
June 18th 2015The first study to assess the effects of DMARDs or anti-TNF treatment in a real world population of patients with inflammatory arthritis shows a clinically significant improvement in work disability, productivity loss, and disease activity-- especially in those receiving TNF-α blockers.
Study: Arthritis Cure Research Is Biased
Plasma-rich platelet injection, an arthritis therapy, is thought to induce regeneration of damaged cartilage. A Netherlands team looked at existing studies and was not convinced that there is credible proof the therapy works. The studies all had a high-to-moderate risk of bias, they found.
Treatment of Plaque Psoriasis Taking Big Steps Forward Part 2
While several new treatment options for plaque psoriasis and psoriatic arthritis have launched in recent years, there is still much work to be done in the field to help patients through long stretches of care.
Stelara Recommended to Treat Psoriatic Arthritis in the United Kingdom
The National Institute for Health and Care Excellence in United Kingdom has recommended Janssen's Stelara for the treatment of psoriatic arthritis, adding to its recommendation of the drug already to treat plaque psoriasis.